Deprescribing
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
While clinical deprescribing trials are increasingly being performed, there is no guidance on the optimum conduction of such…
With increasing age, comorbidity, and frailty, the balance between potential harms and benefits of long-term medication may shift…
The use of opioid drug therapy in older adults has increased over the past decade. Although use of opioid drugs may be clinically…
In January 2017 EJHP published a themed issue on the subject of deprescribing, a ‘hot topic’ for clinicians who are challenged…
INTRODUCTION Multimorbidity in older adults leads to polypharmacy with all its hazardous outcomes and drug‑related problems…
Multimorbidity and associated polypharmacy present a significant and increasing challenge to patients, carers and healthcare…
In their recent article about deprescribing through shared decision making,1 Jansen and colleagues note that many of the triggers…
Dear Editor,
Polypharmacy in paediatrics is not as common as in adults and for various reasons deprescribing is not as…
The risks of polypharmacy are heightened in the elderly because of a number of factors including age-related physiologic changes…
Polypharmacy is commonplace and may have resulted from the implementation of evidence-based guidelines in the care of an…